UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

Clinical cancer research, 2007-04, Vol.13 (8), p.2329-2334

2007

Volltextzugriff (PDF)

EGFR associated expression profiles vary with breast tumor subtype

BMC genomics, 2007-07, Vol.8 (1), p.258-258, Article 258

2007

Volltextzugriff (PDF)

Mechanisms of Disease: radiosensitization by epidermal growth factor receptor inhibitors

Nature clinical practice. Oncology, 2004-12, Vol.1 (2), p.80-87

Sartor, Carolyn I

2004

Volltextzugriff (PDF)

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells

Cancer research (Chicago, Ill.), 2006-06, Vol.66 (12), p.6412-6420

2006

Volltextzugriff (PDF)

American Joint Committee on Cancer Tumor–Node–Metastasis Stage After Neoadjuvant Chemotherapy and Breast Cancer Outcome

JNCI : Journal of the National Cancer Institute, 2005-08, Vol.97 (15), p.1137-1142

2005

Volltextzugriff (PDF)

Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer With Trastuzumab: A Phase II Trial

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (4), p.998-1004

2010

Volltextzugriff (PDF)

Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (13), p.4585-4592

2004

Volltextzugriff (PDF)

Radiosensitization of Epidermal Growth Factor Receptor/HER2–Positive Pancreatic Cancer Is Mediated by Inhibition of Akt Independent of Ras Mutational Status

Clinical cancer research, 2010-02, Vol.16 (3), p.912-923

2010

Volltextzugriff (PDF)

Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf > MEK > ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK

Radiotherapy and oncology, 2009-12, Vol.93 (3), p.639-644

2009

Volltextzugriff (PDF)

Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts

International journal of radiation oncology, biology, physics, 2010-06, Vol.77 (2), p.575-581

2010

Volltextzugriff (PDF)

Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344

Journal of clinical oncology, 2005-01, Vol.23 (1), p.30-40

2005

Volltextzugriff (PDF)

Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (8), p.3404-3409

2005

Volltextzugriff (PDF)

Epidermal growth factor family receptors and inhibitors: Radiation response modulators

Seminars in radiation oncology, 2003-01, Vol.13 (1), p.22-30

Sartor, Carolyn I.

2003

Volltextzugriff (PDF)

Cosmetic Outcomes for Accelerated Partial Breast Irradiation Before Surgical Excision of Early-Stage Breast Cancer Using Single-Dose Intraoperative Radiotherapy

International journal of radiation oncology, biology, physics, 2011-02, Vol.79 (2), p.400-407

2011

Volltextzugriff (PDF)

Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic

Annals of surgical oncology, 2006-05, Vol.13 (5), p.685-691

2006

Volltextzugriff (PDF)

Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1

Molecular and Cellular Biology, 2006-09, Vol.26 (17), p.6412-6424

2006

Volltextzugriff (PDF)

Comparison of three concomitant boost techniques for early-stage breast cancer

International journal of radiation oncology, biology, physics, 2006, Vol.64 (1), p.168-175

2006

Volltextzugriff (PDF)

Phase 2 Study of Pre-Excision Single-Dose Intraoperative Radiation Therapy for Early-Stage Breast Cancers: Six-Year Update With Application of the ASTRO Accelerated Partial Breast Irradiation Consensus Statement Criteria

Cancer, 2013-05, Vol.119 (9), p.1736-1743

2013

Volltextzugriff (PDF)

Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance

International journal of radiation oncology, biology, physics, 2004-02, Vol.58 (2), p.344-352

2004

Volltextzugriff (PDF)

Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways

Cancer research (Chicago, Ill.), 2002-07, Vol.62 (14), p.4142-4150

2002

Volltextzugriff (PDF)

Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer

The oncologist (Dayton, Ohio), 2012-12, Vol.17 (12), p.1496-1503

2012

Volltextzugriff (PDF)

HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer Cells

Molecular and Cellular Biology, 2001-07, Vol.21 (13), p.4265-4275

2001

Volltextzugriff (PDF)

Local Control Following Single-Dose Intraoperative Radiotherapy Prior to Surgical Excision of Early-Stage Breast Cancer

Annals of surgical oncology, 2011-04, Vol.18 (4), p.939-945

2011

Volltextzugriff (PDF)

Phase 2 study of pre‐excision single‐dose intraoperative radiation therapy for early‐stage breast cancers

Cancer, 2013-05, Vol.119 (9), p.1736-1743

2013

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Englisch
(178)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

EGFR associated expression profiles vary with breast tumor subtype

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

Mechanisms of Disease: radiosensitization by epidermal growth factor receptor inhibitors

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells

American Joint Committee on Cancer Tumor–Node–Metastasis Stage After Neoadjuvant Chemotherapy and Breast Cancer Outcome

Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer With Trastuzumab: A Phase II Trial

Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis

Radiosensitization of Epidermal Growth Factor Receptor/HER2–Positive Pancreatic Cancer Is Mediated by Inhibition of Akt Independent of Ras Mutational Status

Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf > MEK > ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK

Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts

Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344

Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer

Epidermal growth factor family receptors and inhibitors: Radiation response modulators

Cosmetic Outcomes for Accelerated Partial Breast Irradiation Before Surgical Excision of Early-Stage Breast Cancer Using Single-Dose Intraoperative Radiotherapy

Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic

Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1

Comparison of three concomitant boost techniques for early-stage breast cancer

Phase 2 Study of Pre-Excision Single-Dose Intraoperative Radiation Therapy for Early-Stage Breast Cancers: Six-Year Update With Application of the ASTRO Accelerated Partial Breast Irradiation Consensus Statement Criteria

Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance

Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways

Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer

HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer Cells

Local Control Following Single-Dose Intraoperative Radiotherapy Prior to Surgical Excision of Early-Stage Breast Cancer

Phase 2 study of pre‐excision single‐dose intraoperative radiation therapy for early‐stage breast cancers

Suchergebnisse filtern